Target intelligence / Profile preview

Vascular smooth muscle cells and pericytes (VSMC/PC)

Target
VSMC/PC
Molecular classification
Cell type, Mural cells
01

Overview

Vascular smooth muscle cells (VSMCs) and pericytes, collectively known as mural cells, are the contractile components of the vasculature. VSMCs wrap around larger vessels like arteries and veins to regulate blood pressure and flow through contraction and relaxation [StatPearls: Physiology, Smooth Muscle]. Pericytes are embedded within the basement membrane of capillaries and microvessels, playing a critical role in maintaining the blood-brain barrier, vascular stability, and angiogenesis [NIH: Pericytes in the Neurovascular Unit]. While these cells are essential for cardiovascular health, their dysfunction is central to pathologies such as hypertension, atherosclerosis, and diabetic microangiopathy [PubMed: Mural Cell Dysfunction in Disease]. Therapeutic strategies often target specific molecular pathways within these cells, such as calcium signaling or growth factor receptors, rather than the cells themselves as a single entity [PubChem: Amlodipine; PubMed: PDGFR signaling in pericytes]. Consequently, this entry refers to a cellular population rather than a specific protein or gene target.

Other names
Mural cellsVascular mural cellsContractile vascular cells
02

Mechanism of action

Drugs targeting these cells typically act via calcium channel blockade, nitric oxide donation, or antagonism of receptors like the angiotensin II or endothelin receptors to modulate vascular tone and proliferation.

03

Biological functions

VasoconstrictionVasodilationVascular integrityAngiogenesisBlood-brain barrier maintenanceBlood pressure regulation
04

Disease associations

HypertensionAtherosclerosisDiabetic retinopathyStrokeVascular dementiaAneurysm
05

Safety considerations

HypotensionPeripheral edemaImpaired wound healingVascular leakageAltered blood-brain barrier permeability
06

Interacting drugs

Amlodipine

5 more in the full profile.

07

Biomarkers

Alpha-smooth muscle actin (ACTA2)Platelet-derived growth factor receptor beta (PDGFRB)Neural/glial antigen 2 (CSPG4)Desmin (DES)Regulator of G-protein signaling 5 (RGS5)

Beyond the preview

Go deeper on Vascular smooth muscle cells and pericytes (VSMC/PC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular smooth muscle cells and pericytes (VSMC/PC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call